China's Brain-Computer Interface Industry Gains Momentum with New Startup Gestala
Gestala, a recently founded Chinese brain-computer interface (BCI) startup, is poised to tap into the country's burgeoning BCI industry. Unlike existing BCIs that rely on invasive implants, Gestala plans to use non-invasive ultrasound technology to access and read from the brain.
The company's CEO and co-founder, Phoenix Peng, aims to develop a device that uses focused ultrasound to stimulate the brain and treat chronic pain. Pilot studies have shown promising results in reducing pain intensity in patients for up to a week. Gestala's first-generation device is expected to be a stationary benchtop machine, where patients would need to visit a clinic to receive treatment.
Gestala's second-generation wearable helmet is currently under development, allowing patients to use it at home with the guidance of a physician. The company's long-term goal is to expand its technology to other indications, such as depression, stroke rehabilitation, Alzheimer's disease, and sleep disorders.
Unlike traditional BCIs that rely on detecting electrical signals from neurons, Gestala's ultrasound-based interface measures changes in brain blood flow. While this approach presents engineering challenges, Peng believes it offers a promising alternative for accessing the entire brain, rather than just isolated regions like the motor cortex.
Gestala's name is inspired by Gestalt psychology, which emphasizes the importance of understanding complex systems as a whole, rather than their individual parts. The company's cofounder, Tianqiao Chen, is also involved in establishing a neuroscience research institute, highlighting the growing interest in harnessing the power of BCI technology.
Neuroscience experts have expressed caution about the feasibility and practicality of ultrasound-based BCI technology. Maximilian Riesenhuber, a professor at Georgetown University, notes that extracting information from the brain with ultrasound is an ambitious goal, requiring significant advances in signal processing and interpretation. However, Gestala's vision resonates with the broader aspirations of the BCI industry: to develop technologies that can improve human cognition, enhance neural functions, and ultimately lead to healthier brains.
As Gestala embarks on its journey to revolutionize brain-computer interfaces, it joins a growing list of startups and research institutions pushing the boundaries of what is possible in this rapidly evolving field.
Gestala, a recently founded Chinese brain-computer interface (BCI) startup, is poised to tap into the country's burgeoning BCI industry. Unlike existing BCIs that rely on invasive implants, Gestala plans to use non-invasive ultrasound technology to access and read from the brain.
The company's CEO and co-founder, Phoenix Peng, aims to develop a device that uses focused ultrasound to stimulate the brain and treat chronic pain. Pilot studies have shown promising results in reducing pain intensity in patients for up to a week. Gestala's first-generation device is expected to be a stationary benchtop machine, where patients would need to visit a clinic to receive treatment.
Gestala's second-generation wearable helmet is currently under development, allowing patients to use it at home with the guidance of a physician. The company's long-term goal is to expand its technology to other indications, such as depression, stroke rehabilitation, Alzheimer's disease, and sleep disorders.
Unlike traditional BCIs that rely on detecting electrical signals from neurons, Gestala's ultrasound-based interface measures changes in brain blood flow. While this approach presents engineering challenges, Peng believes it offers a promising alternative for accessing the entire brain, rather than just isolated regions like the motor cortex.
Gestala's name is inspired by Gestalt psychology, which emphasizes the importance of understanding complex systems as a whole, rather than their individual parts. The company's cofounder, Tianqiao Chen, is also involved in establishing a neuroscience research institute, highlighting the growing interest in harnessing the power of BCI technology.
Neuroscience experts have expressed caution about the feasibility and practicality of ultrasound-based BCI technology. Maximilian Riesenhuber, a professor at Georgetown University, notes that extracting information from the brain with ultrasound is an ambitious goal, requiring significant advances in signal processing and interpretation. However, Gestala's vision resonates with the broader aspirations of the BCI industry: to develop technologies that can improve human cognition, enhance neural functions, and ultimately lead to healthier brains.
As Gestala embarks on its journey to revolutionize brain-computer interfaces, it joins a growing list of startups and research institutions pushing the boundaries of what is possible in this rapidly evolving field.